Antibody pre-targeted therapeutics offer ... The BsAb should be of human origin to minimize the induction of human anti-mouse immune responses that limit repeat dosing. The BsAb should not contain ...

Combination treatment could also benefit patients with lung, bowel, pancreatic and other solid cancers who don’t respond to ...

Researchers say, “It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while ...

Blood from a former construction and factory worker — and self-taught herpetologist — could hold the key to a universal antivenom.

SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models.

Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling ...

BACKGROUND: Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation ...

New research, conducted by scientists at the University of California – Los Angeles Health Sciences (UCLA), shows a widely ...

Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and ...

This study presents an important finding on the role of GATA4 in aging and OA-associated cartilage pathology. The evidence supporting the conclusions is compelling, with rigorous in vitro and in vivo ...